Tarsus Pharmaceuticals IncNASDAQ:TARS
- LAST PRICE38.2400
- TODAY'S CHANGE (%)-0.3400 (-0.8813%)
- Bid / Lots36.2500/ 2
- Ask / Lots40.5000/ 2
- Open / Previous Close38.6000 / 38.5800
- Day Range
- 52 Week Range
- Volume586,985
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TARS |
|---|---|---|
| 09:32 ET | 7637 | 38.08 |
| 09:34 ET | 939 | 38.335 |
| 09:36 ET | 200 | 38.15 |
| 09:38 ET | 300 | 37.83 |
| 09:39 ET | 300 | 37.94 |
| 09:41 ET | 100 | 37.82 |
| 09:43 ET | 300 | 37.66 |
| 09:45 ET | 200 | 37.64 |
| 09:48 ET | 200 | 37.64 |
| 09:50 ET | 625 | 37.4 |
| 09:52 ET | 200 | 37.21 |
| 09:54 ET | 100 | 37.09 |
| 09:56 ET | 200 | 36.98 |
| 09:57 ET | 700 | 36.83 |
| 09:59 ET | 1595 | 36.9326 |
| 10:01 ET | 878 | 37.24 |
| 10:03 ET | 300 | 37.24 |
| 10:06 ET | 2141 | 37.25 |
| 10:08 ET | 100 | 37.13 |
| 10:10 ET | 400 | 37.255 |
| 10:12 ET | 100 | 37.12 |
| 10:14 ET | 3067 | 37.54 |
| 10:17 ET | 200 | 37.66 |
| 10:19 ET | 4061 | 37.395 |
| 10:24 ET | 200 | 37.2 |
| 10:26 ET | 1658 | 37.12 |
| 10:28 ET | 3604 | 37.205 |
| 10:30 ET | 100 | 37.21 |
| 10:32 ET | 500 | 37.26 |
| 10:33 ET | 400 | 37.2 |
| 10:35 ET | 200 | 37.135 |
| 10:37 ET | 2148 | 37.22 |
| 10:39 ET | 200 | 37.31 |
| 10:42 ET | 2029 | 37.14 |
| 10:44 ET | 500 | 37.23 |
| 10:46 ET | 300 | 37.15 |
| 10:48 ET | 600 | 37.265 |
| 10:50 ET | 100 | 37.345 |
| 10:51 ET | 500 | 37.53 |
| 10:53 ET | 1591 | 37.45 |
| 10:55 ET | 100 | 37.45 |
| 10:57 ET | 4323 | 37.09 |
| 11:00 ET | 400 | 36.99 |
| 11:02 ET | 895 | 37.235 |
| 11:04 ET | 3852 | 37.63 |
| 11:06 ET | 2506 | 37.66 |
| 11:08 ET | 593 | 37.68 |
| 11:09 ET | 400 | 37.85 |
| 11:11 ET | 600 | 37.795 |
| 11:13 ET | 100 | 37.775 |
| 11:15 ET | 1300 | 37.69 |
| 11:18 ET | 1044 | 37.66 |
| 11:20 ET | 300 | 37.665 |
| 11:22 ET | 400 | 37.66 |
| 11:24 ET | 200 | 37.69 |
| 11:26 ET | 1000 | 37.62 |
| 11:27 ET | 1200 | 37.545 |
| 11:29 ET | 200 | 37.59 |
| 11:31 ET | 700 | 37.59 |
| 11:33 ET | 562 | 37.5 |
| 11:38 ET | 500 | 37.605 |
| 11:40 ET | 1700 | 37.71 |
| 11:42 ET | 936 | 37.74 |
| 11:44 ET | 2462 | 37.84 |
| 11:45 ET | 1654 | 37.86 |
| 11:47 ET | 300 | 37.835 |
| 11:49 ET | 1000 | 37.65 |
| 11:51 ET | 503 | 37.57 |
| 11:54 ET | 1333 | 37.565 |
| 11:56 ET | 783 | 37.64 |
| 11:58 ET | 100 | 37.595 |
| 12:00 ET | 400 | 37.705 |
| 12:02 ET | 2903 | 37.52 |
| 12:03 ET | 425 | 37.565 |
| 12:05 ET | 1507 | 37.51 |
| 12:07 ET | 210 | 37.51 |
| 12:09 ET | 526 | 37.525 |
| 12:12 ET | 200 | 37.51 |
| 12:14 ET | 400 | 37.51 |
| 12:16 ET | 705 | 37.565 |
| 12:18 ET | 300 | 37.56 |
| 12:20 ET | 417 | 37.57 |
| 12:21 ET | 800 | 37.595 |
| 12:23 ET | 860 | 37.58 |
| 12:25 ET | 100 | 37.51 |
| 12:27 ET | 543 | 37.54 |
| 12:30 ET | 208 | 37.51 |
| 12:32 ET | 200 | 37.555 |
| 12:34 ET | 800 | 37.51 |
| 12:36 ET | 323 | 37.51 |
| 12:38 ET | 615 | 37.51 |
| 12:39 ET | 408 | 37.54 |
| 12:41 ET | 800 | 37.51 |
| 12:43 ET | 925 | 37.51 |
| 12:45 ET | 2181 | 37.51 |
| 12:48 ET | 1100 | 37.505 |
| 12:50 ET | 300 | 37.505 |
| 12:52 ET | 1173 | 37.55 |
| 12:54 ET | 400 | 37.58 |
| 12:56 ET | 599 | 37.605 |
| 12:57 ET | 1155 | 37.53 |
| 12:59 ET | 200 | 37.49 |
| 01:01 ET | 6104 | 37.32 |
| 01:06 ET | 1162 | 37.05 |
| 01:08 ET | 300 | 37.03 |
| 01:10 ET | 100 | 37.08 |
| 01:12 ET | 500 | 37.02 |
| 01:14 ET | 200 | 36.96 |
| 01:15 ET | 1659 | 37.275 |
| 01:17 ET | 200 | 37.305 |
| 01:19 ET | 200 | 37.315 |
| 01:21 ET | 200 | 37.29 |
| 01:24 ET | 1100 | 37.335 |
| 01:26 ET | 200 | 37.26 |
| 01:28 ET | 400 | 37.3 |
| 01:30 ET | 200 | 37.32 |
| 01:32 ET | 300 | 37.33 |
| 01:33 ET | 3583 | 37.44 |
| 01:35 ET | 127 | 37.4463 |
| 01:37 ET | 1109 | 37.53 |
| 01:42 ET | 1620 | 37.73 |
| 01:44 ET | 400 | 37.73 |
| 01:46 ET | 300 | 37.785 |
| 01:48 ET | 463 | 37.845 |
| 01:50 ET | 420 | 37.91 |
| 01:51 ET | 1270 | 37.86 |
| 01:53 ET | 1110 | 37.73 |
| 01:55 ET | 300 | 37.65 |
| 01:57 ET | 200 | 37.52 |
| 02:00 ET | 100 | 37.37 |
| 02:02 ET | 400 | 37.23 |
| 02:04 ET | 300 | 37 |
| 02:06 ET | 3535 | 37.245 |
| 02:09 ET | 100 | 37.26 |
| 02:11 ET | 100 | 37.26 |
| 02:13 ET | 200 | 37.34 |
| 02:15 ET | 800 | 37.21 |
| 02:18 ET | 1536 | 37.38 |
| 02:22 ET | 100 | 37.44 |
| 02:24 ET | 100 | 37.44 |
| 02:26 ET | 700 | 37.4 |
| 02:27 ET | 300 | 37.47 |
| 02:33 ET | 150 | 37.3712 |
| 02:36 ET | 900 | 37.325 |
| 02:40 ET | 2284 | 37.415 |
| 02:42 ET | 700 | 37.445 |
| 02:44 ET | 100 | 37.41 |
| 02:45 ET | 100 | 37.51 |
| 02:49 ET | 300 | 37.51 |
| 02:51 ET | 400 | 37.69 |
| 02:54 ET | 940 | 37.775 |
| 02:56 ET | 600 | 37.835 |
| 02:58 ET | 500 | 37.98 |
| 03:00 ET | 800 | 37.9 |
| 03:02 ET | 3542 | 38.04 |
| 03:03 ET | 800 | 38.07 |
| 03:05 ET | 1639 | 38.085 |
| 03:07 ET | 3684 | 38.07 |
| 03:09 ET | 400 | 38.12 |
| 03:12 ET | 300 | 38.1 |
| 03:14 ET | 1700 | 38.11 |
| 03:16 ET | 900 | 38.07 |
| 03:18 ET | 2708 | 38.05 |
| 03:20 ET | 400 | 38.09 |
| 03:21 ET | 100 | 38.11 |
| 03:23 ET | 1200 | 38.105 |
| 03:25 ET | 200 | 38.1 |
| 03:27 ET | 2257 | 38.09 |
| 03:30 ET | 1100 | 38.05 |
| 03:32 ET | 487 | 38.09 |
| 03:34 ET | 100 | 38.14 |
| 03:36 ET | 300 | 38.15 |
| 03:38 ET | 2674 | 38.095 |
| 03:39 ET | 1100 | 38.19 |
| 03:41 ET | 800 | 38.175 |
| 03:43 ET | 800 | 38.125 |
| 03:45 ET | 2300 | 38.225 |
| 03:48 ET | 1500 | 38.19 |
| 03:50 ET | 2532 | 38.23 |
| 03:52 ET | 1400 | 38.26 |
| 03:54 ET | 1723 | 38.34 |
| 03:56 ET | 15575 | 38.39 |
| 03:57 ET | 5465 | 38.3 |
| 03:59 ET | 15195 | 38.24 |
May 13, 2024
DJ Tarsus Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co., from 11:16AM ET on Monday May 13, 2024 by Dow Jones
11:16AM ET on Monday May 13, 2024 by Dow Jones
May 10, 2024
DJ Tarsus Pharmaceuticals Is Maintained at Overweight by Barclays, from 3:27PM ET on Friday May 10, 2024 by Dow Jones
3:27PM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference, from 5:00PM ET on Thursday May 09, 2024 by Dow Jones
5:00PM ET on Thursday May 09, 2024 by Dow JonesDJ Tarsus Pharmaceuticals Is Maintained at Outperform by Oppenheimer, from 12:56PM ET on Thursday May 09, 2024 by Dow Jones
12:56PM ET on Thursday May 09, 2024 by Dow Jones
May 8, 2024
Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements, from 4:05PM ET on Wednesday May 08, 2024 by Dow Jones
4:05PM ET on Wednesday May 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tarsus Pharmaceuticals Inc | 1.5B | -8.1x | --- |
Avadel Pharmaceuticals PLC | 1.5B | -8.3x | --- |
Liquidia Corp | 973.1M | -8.1x | --- |
Petro USA Inc | 1.0B | -31,250.0x | --- |
Pliant Therapeutics Inc | 941.7M | -5.3x | --- |
Ligand Pharmaceuticals Inc | 1.5B | 16.4x | -12.71% |
Company Information
Tarsus Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics, starting with eye care. The Company’s lead product candidate, XDEMVY is a lotilaner ophthalmic solution that targets and eradicates the root cause of Demodex blepharitis, Demodex mite infestation. The active pharmaceutical ingredient (API) of XDEMVY, lotilaner, paralyzes and eradicates mites and other parasites through the inhibition of parasite-specific gamma-aminobutyric acid-gated chloride channels. The Company investigating the development of its product candidates to address targeted diseases with high unmet medical needs, which include TP-03 for the potential treatment of Meibomian Gland Disease (MGD), TP-04, a novel gel formulation of lotilaner for the potential treatment of rosacea, and TP-05, a novel investigative oral formulation of lotilaner, for potential Lyme disease prophylaxis and community malaria reduction.
Contact Information
- Headquarters
- 15440 Laguna Canyon RoadIRVINE, CA, United States 92618
- Phone
- 949-409-9820
- Fax
- 302-531-3150
Executives
- Chairman of the Board, President, Chief Executive Officer, Co-Founder
- Bobak Azamian
- Chief Financial Officer and Chief Strategy Officer
- Jeffrey Farrow
- Chief Operating Officer
- Seshadri Neervannan
- Chief Human Resources Officer
- Dianne Whitfield
- General Counsel, Secretary
- Bryan Wahl
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.5B |
|---|---|
Revenue (TTM) | $42.6M |
Shares Outstanding | 37.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.17 |
EPS | $-4.72 |
Book Value | $5.76 |
P/E Ratio | -8.1x |
Price/Sales (TTM) | 34.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -366.27% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
